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ABSTRACT
Authoratative government pandemic preparedness requires an evidence-based approach. The scientiﬁc advisory process that has informed the
current UK pandemic preparedness plans is described. The ﬁnal endorsed scientiﬁc papers are now publicly available.
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Public expectations of effective government interventions in
health crises are high in developed countries. Authoritative
action and provision of information to the public can help in
avoiding public disquiet or panic and in mitigating the societal
risks of a pandemic, complementing the direct health effects
of any interventions. Conversely, disagreement over the scien-
tiﬁc evidence base, particularly where considerable uncertain-
ties and gaps in information exist, can open the way to
debate based primarily on established beliefs and prejudices.
In the face of a future event such as an inﬂuenza pandemic,
the timing and precise nature of which is unknown, robust
preparation will be strengthened by an agreed scientiﬁc under-
standing of the risks and the options for response.
The UK Government has followed an extensive process
to review and conﬁrm an agreed summary of the inter-
national evidence base. This underpins policy development
on countermeasures within its pandemic inﬂuenza prepared-
ness programme and can be of use to other countries devel-
oping pandemic preparedness plans as well.
Under the auspices of the UK Scientiﬁc Advisory Group
on Pandemic Inﬂuenza, ﬁve scientiﬁc papers dealing with
the main clinical countermeasures (antivirals, pre-pandemic
and pandemic speciﬁc vaccines, antibiotics and facemasks)
and the risk of a pandemic originating from an H5N1 virus
were developed. These papers were reviewed and revised
by additional national and international expert scientiﬁc
reviewers and subsequently at a colloquium, convened by
the Secretary of State for Health, of scientiﬁc experts.
Revised papers were then submitted to the Scientiﬁc
Advisory Group for ﬁnal endorsement as reﬂecting an accu-
rate and comprehensive summary of the state of knowledge
in June 2007. The ﬁnal endorsed papers have now been
made publicly available as a resource to all.
1
Papers reviewing the scientiﬁc evidence base in the following
areas are available at: http://www.advisorybodies.doh.gov.uk/
spi/evidence.htm
(i) The use of antiviral drugs in a pandemic;
(ii) pre-pandemic and pandemic speciﬁc inﬂuenza vaccines;
(iii) the use of antibiotics for pandemic inﬂuenza;
(iv) the use of face masks during a pandemic; and
(v) the risk of a pandemic originating from H5N1.
This widely agreed scientiﬁc state of the art offers a
ﬁrm foundation for complex and potentially expensive policy
and procurement decisions on pandemic countermeasures.
Within the UK, the papers have already informed the recently
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2 and policy statement.
3 They will con-
tinue to inform policy decisions across Government.
The scientiﬁc knowledge in this ﬁeld is continually evol-
ving and improving, and the UK will therefore continue to
review and reﬁne its assessment of the evidence base.
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